Andrea M. Ragonese

Array ( [id] => 2892113 [patent_doc_number] => 05210181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-11 [patent_title] => 'T-lymphotropic retrovirus peptide' [patent_app_type] => 1 [patent_app_number] => 7/825447 [patent_app_country] => US [patent_app_date] => 1992-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 3627 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/210/05210181.pdf [firstpage_image] =>[orig_patent_app_number] => 825447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2974493 [patent_doc_number] => 05256561 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-26 [patent_title] => 'Monoclonal antibody to HIV-2 and uses thereof' [patent_app_type] => 1 [patent_app_number] => 7/811592 [patent_app_country] => US [patent_app_date] => 1991-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8654 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/256/05256561.pdf [firstpage_image] =>[orig_patent_app_number] => 811592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2963574 [patent_doc_number] => 05274081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-28 [patent_title] => 'Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen' [patent_app_type] => 1 [patent_app_number] => 7/789743 [patent_app_country] => US [patent_app_date] => 1991-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4006 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/274/05274081.pdf [firstpage_image] =>[orig_patent_app_number] => 789743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2933019 [patent_doc_number] => 05246844 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-21 [patent_title] => 'Virulence associated proteins in Borrelia burgdorferi (BB)' [patent_app_type] => 1 [patent_app_number] => 7/781355 [patent_app_country] => US [patent_app_date] => 1991-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 10 [patent_no_of_words] => 15479 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/246/05246844.pdf [firstpage_image] =>[orig_patent_app_number] => 781355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3090978 [patent_doc_number] => 05290688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-01 [patent_title] => 'Method for intensive, in vitro culture of Babesia divergens strains' [patent_app_type] => 1 [patent_app_number] => 7/752625 [patent_app_country] => US [patent_app_date] => 1991-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7014 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/290/05290688.pdf [firstpage_image] =>[orig_patent_app_number] => 752625 [rel_patent_id] =>[rel_patent_doc_number] =>)